Springhill-Fund-Asset-Management-Hk-Co

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
19
Total Value
20867368
Accession Number
0001911270-25-000003
Form Type
13F-HR
Manager Name
Springhill-Fund-Asset-Management-Hk-Co
Data Enrichment
100% identified
19 identified0 unidentified

Holdings

19 positions • $20.9M total value
Manager:
Search and click to pin securities to the top
Verona Pharma plc
Shares:63.5K
Value:$4.0M
% of Portfolio:19.3% ($4.0M/$20.9M)
Summit Therapeutics Inc.
Shares:124.3K
Value:$2.4M
% of Portfolio:11.5% ($2.4M/$20.9M)
Janux Therapeutics, Inc.
Shares:78.5K
Value:$2.1M
% of Portfolio:10.2% ($2.1M/$20.9M)
REGENERON PHARMACEUTICALS, INC.
Shares:2.6K
Value:$1.6M
% of Portfolio:7.9% ($1.6M/$20.9M)
NEUROCRINE BIOSCIENCES INC
Shares:13.6K
Value:$1.5M
% of Portfolio:7.2% ($1.5M/$20.9M)
INSMED Inc
Shares:19.2K
Value:$1.5M
% of Portfolio:7.0% ($1.5M/$20.9M)
SOLENO THERAPEUTICS INC
Shares:19.9K
Value:$1.4M
% of Portfolio:6.8% ($1.4M/$20.9M)
Jazz Pharmaceuticals plc
Shares:9.9K
Value:$1.2M
% of Portfolio:5.9% ($1.2M/$20.9M)
Akero Therapeutics, Inc.
Shares:19.9K
Value:$806.6K
% of Portfolio:3.9% ($806.6K/$20.9M)
ARGENX SE
Shares:1.1K
Value:$678.3K
% of Portfolio:3.3% ($678.3K/$20.9M)
ELI LILLY & Co
Shares:816
Value:$673.9K
% of Portfolio:3.2% ($673.9K/$20.9M)
Protagonist Therapeutics, Inc
Shares:12.9K
Value:$621.9K
% of Portfolio:3.0% ($621.9K/$20.9M)
TG THERAPEUTICS, INC.
Shares:13.5K
Value:$532.3K
% of Portfolio:2.6% ($532.3K/$20.9M)
Tarsus Pharmaceuticals, Inc.
Shares:7.1K
Value:$363.5K
% of Portfolio:1.7% ($363.5K/$20.9M)
Ascendis Pharma A/S
Shares:2.2K
Value:$338.7K
% of Portfolio:1.6% ($338.7K/$20.9M)
RHYTHM PHARMACEUTICALS, INC.
Shares:6.3K
Value:$332.5K
% of Portfolio:1.6% ($332.5K/$20.9M)
BioNTech SE
Shares:3.0K
Value:$273.2K
% of Portfolio:1.3% ($273.2K/$20.9M)
SpringWorks Therapeutics, Inc.
Shares:5.9K
Value:$260.2K
% of Portfolio:1.2% ($260.2K/$20.9M)
Cogent Biosciences, Inc.
Shares:29.5K
Value:$176.7K
% of Portfolio:0.8% ($176.7K/$20.9M)